915
Views
4
CrossRef citations to date
0
Altmetric
Reviews

A systematic review of second line therapies in toxic seizures

, ORCID Icon, , , , ORCID Icon & show all
Pages 451-456 | Received 21 Oct 2020, Accepted 18 Feb 2021, Published online: 23 Mar 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

D. W. Huntjens, E. P. S. Weersink, D. L. Hilarius, N. C. Ran & E. J. F. Franssen. (2022) Severe epileptic seizures after accidental MDMA exposure in a 14-month-old child. Clinical Toxicology 60:5, pages 657-657.
Read now

Articles from other publishers (3)

Patrick J. Coppler & Jonathan Elmer. (2023) Status Epilepticus. Critical Care Clinics 39:1, pages 87-102.
Crossref
Jennifer P. Pascali, Arianna Giorgetti, Rossella Barone, Guido Pelletti & Paolo Fais. (2022) Valproic acid determination by liquid chromatography coupled to mass spectrometry (LC–MS/MS) in whole blood for forensic purposes. Drug Testing and Analysis 15:1, pages 128-133.
Crossref
Zlatan Coralic, Jaideep Kapur, Kent R. Olson, James M. Chamberlain, Daniel Overbeek & Robert Silbergleit. (2022) Treatment of Toxin-Related Status Epilepticus With Levetiracetam, Fosphenytoin, or Valproate in Patients Enrolled in the Established Status Epilepticus Treatment Trial. Annals of Emergency Medicine 80:3, pages 194-202.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.